Bank Of New York Mellon Corp Athenex, Inc. Transaction History

Bank Of New York Mellon Corp

$538 Trillion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$0.12 - $0.21 $4,835 - $8,462	40,297 New	40,297 $6,000
Q3 2022 Nov 14, 2022	BUY	$0.24 - $1.11 $0 - $1	1 Added 0.0%	40,297 $11,000
Q2 2022 Aug 15, 2022	SELL	$0.41 - $0.91 $97,460 - $216,314	-237,708 Reduced 85.51%	40,296 $16,000
Q1 2022 May 11, 2022	SELL	$0.79 - $1.59 $2,307 - $4,644	-2,921 Reduced 1.04%	278,004 $230,000
Q4 2021 Feb 11, 2022	BUY	$1.36 - $2.94 $520 - $1,126	383 Added 0.14%	280,925 $382,000
Q3 2021 Nov 12, 2021	BUY	$2.97 - $4.84 $55,093 - $89,782	18,550 Added 7.08%	280,542 $844,000
Q2 2021 Aug 11, 2021	BUY	$3.71 - $5.13 $39,025 - $53,962	10,519 Added 4.18%	261,992 $1.21 Million
Q1 2021 May 13, 2021	SELL	$4.08 - $14.75 $46,369 - $167,633	-11,365 Reduced 4.32%	251,473 $1.08 Million
Q4 2020 Feb 09, 2021	BUY	$11.06 - $14.01 $227,979 - $288,788	20,613 Added 8.51%	262,838 $2.91 Million
Q3 2020 Nov 12, 2020	SELL	$10.26 - $14.55 $285,638 - $405,072	-27,840 Reduced 10.31%	242,225 $2.93 Million
Q2 2020 Aug 12, 2020	BUY	$7.11 - $13.76 $68,177 - $131,944	9,589 Added 3.68%	270,065 $3.72 Million
Q1 2020 May 06, 2020	BUY	$5.71 - $15.85 $30,063 - $83,450	5,265 Added 2.06%	260,476 $2.02 Million
Q4 2019 Feb 14, 2020	BUY	$9.6 - $17.75 $141,321 - $261,297	14,721 Added 6.12%	255,211 $3.9 Million
Q3 2019 Nov 07, 2019	BUY	$12.16 - $21.0 $273,150 - $471,723	22,463 Added 10.3%	240,490 $2.92 Million
Q2 2019 Aug 12, 2019	BUY	$9.44 - $19.8 $441,990 - $927,055	46,821 Added 27.35%	218,027 $4.32 Million
Q1 2019 May 14, 2019	BUY	$11.11 - $13.49 $25,952 - $31,512	2,336 Added 1.38%	171,206 $2.1 Million
Q4 2018 Feb 11, 2019	BUY	$10.24 - $15.49 $40,017 - $60,534	3,908 Added 2.37%	168,870 $2.14 Million
Q3 2018 Nov 09, 2018	BUY	$15.53 - $19.97 $16,601 - $21,347	1,069 Added 0.65%	164,962 $0
Q2 2018 Aug 06, 2018	BUY	$15.88 - $19.5 $1.67 Million - $2.05 Million	104,918 Added 177.9%	163,893 $3.06 Million
Q1 2018 May 15, 2018	BUY	$13.53 - $17.47 $435,828 - $562,743	32,212 Added 120.36%	58,975 $1 Million
Q4 2017 Feb 09, 2018	BUY	$14.41 - $19.15 $385,654 - $512,511	26,763	26,763 $426,000

Others Institutions Holding ATNX

# of Institutions

Shares Held

1.46M

Call Options Held

Put Options Held

Empery Asset Management, LP New York, NY

1.45M
Shares

$14,521
2.33% of portfolio
Eaton Vance Management Boston, MA

12K
Shares

$120
0.0% of portfolio
Concourse Financial Group Securities, Inc. Birmingham, AL

0
Shares

$0
0.0% of portfolio

View Full List

About Athenex, Inc.

Ticker ATNX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 156,790,000
Market Cap $1.57M
Description
Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of cancer. It operates through three segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform. The company's Orascovery product candidates include Oral paclitaxel and encequidar,...

More about ATNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account